Singapore - English - HSA (Health Sciences Authority)

ehc commercial singapore pte. ltd. - general hospital - cavicide is disinfectant/decontaminant cleaner for dental and medical devices: bactericidal, virucidal, fungicidal, tuberculocidal.

Australia - English - Department of Health (Therapeutic Goods Administration)

kerr australia pty ltd - 35863 - impression material, dental, alginate - an alginate impression material with a colour change indicator and prolonged pouring time used in dental prosthetics and orthodontics.

Australia - English - Department of Health (Therapeutic Goods Administration)

kerr australia pty ltd - 34799 - impression material, dental, compound - impression compound is used for full or partial dental impressions.

Australia - English - Department of Health (Therapeutic Goods Administration)

kerr australia pty ltd - 38584 - bite registration device, bite rim wax, plate - used in dentistry to check occlusal relationships of teeth.

European Union - English - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

European Union - English - EMA (European Medicines Agency)

glaxo group ltd. - amprenavir - hiv infections - antivirals for systemic use - agenerase, in combination with other antiretroviral agents, is indicated for the treatment of protease inhibitor (pi) experienced hiv-1 infected adults and children above the age of 4 years. agenerase capsules should normally be administered with low dose ritonavir as a pharmacokinetic enhancer of amprenavir (see sections 4.2 and 4.5). the choice of amprenavir should be based on individual viral resistance testing and treatment history of patients (see section 5.1).the benefit of agenerase boosted with ritonavir has not been demonstrated in pi nave patients (see section 5.1)

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - live recombinant e2 gene-deleted bovine viral diarrhoea virus containing classical swine fever virus e2 gene (cp7_e2alf) - live viral vaccines, immunologicals for suidae - pigs - for active immunisation of pigs from 7 weeks of age onwards to prevent mortality and reduce infection and disease caused by classical swine fever virus (csfv).onset of immunity: 14 days after vaccinationduration of immunity: at least 6 months after vaccinationfor active immunisation of breeding females to reduce transplacental infection caused by csfv.onset of immunity: 21 days after vaccinationduration of immunity has not been demonstrated.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - porcine parvovirus, strain 27a, viral protein 2 - immunologicals for suidae - pigs - for active immunisation of gilts and sows from the age of 5 months to protect progeny against transplacental infection caused by porcine parvovirus.

European Union - English - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren, amlodipine, hydrochlorothiazide - hypertension - cardiovascular system - rasitrio is indicated for the treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of aliskiren, amlodipine and hydrochlorothiazide given concurrently at the same dose level as in the combination.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

roche products ltd - trastuzumab - powder for solution for infusion - 150mg